tranexamic acid has been researched along with Placenta Previa in 7 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Placenta Previa: Abnormal placentation in which the PLACENTA implants in the lower segment of the UTERUS (the zone of dilation) and may cover part or all of the opening of the CERVIX. It is often associated with serious antepartum bleeding and PREMATURE LABOR.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effect of adjunctive intravenous tranexamic acid (TA) on blood loss during cesarean section (CS) in patients with placenta previa undergone bilateral uterine arteryligation (BUAL)." | 9.30 | Bilateral uterine artery ligation plus intravenous tranexamic acid during cesarean delivery for placenta previa: a randomized double-blind controlled trial. ( Abbas, AM; Sallam, HF; Shady, NW, 2019) |
| "Placenta previa affects approximately 4 per 1000 pregnancies and increases the risk of antepartum bleeding, emergent preterm labour and emergency caesarean sections." | 5.91 | Use of tranexamic acid (TXA) to reduce preterm birth and other adverse obstetrical outcomes among pregnant individuals with placenta previa: a systematic review protocol. ( Muldoon, KA; Seguin, N; Visintini, S; Walker, M, 2023) |
| "To investigate the effect of adjunctive intravenous tranexamic acid (TA) on blood loss during cesarean section (CS) in patients with placenta previa undergone bilateral uterine arteryligation (BUAL)." | 5.30 | Bilateral uterine artery ligation plus intravenous tranexamic acid during cesarean delivery for placenta previa: a randomized double-blind controlled trial. ( Abbas, AM; Sallam, HF; Shady, NW, 2019) |
| " A rapid recourse to prostaglandins (sulprostone in France) may reverse uterine atony." | 3.83 | Major obstetric hemorrhage. ( Le Gouez, A; Mercier, FJ, 2016) |
| " The effectiveness of treatment methods and the optimal dosage of misoprostol are research priorities." | 2.53 | Preventing deaths due to haemorrhage. ( Hofmeyr, GJ; Qureshi, Z, 2016) |
| "Placenta previa affects approximately 4 per 1000 pregnancies and increases the risk of antepartum bleeding, emergent preterm labour and emergency caesarean sections." | 1.91 | Use of tranexamic acid (TXA) to reduce preterm birth and other adverse obstetrical outcomes among pregnant individuals with placenta previa: a systematic review protocol. ( Muldoon, KA; Seguin, N; Visintini, S; Walker, M, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Seguin, N | 1 |
| Visintini, S | 1 |
| Muldoon, KA | 1 |
| Walker, M | 1 |
| Hajmurad, OS | 1 |
| Choxi, AA | 1 |
| Zahid, Z | 1 |
| Dudaryk, R | 1 |
| Abbas, AM | 1 |
| Shady, NW | 1 |
| Sallam, HF | 1 |
| Mauritz, AA | 1 |
| Dominguez, JE | 1 |
| Guinn, NR | 1 |
| Gilner, J | 1 |
| Habib, AS | 1 |
| Hofmeyr, GJ | 1 |
| Qureshi, Z | 1 |
| Le Gouez, A | 1 |
| Mercier, FJ | 1 |
| Valsecchi, A | 1 |
| Cappelletti, M | 1 |
1 review available for tranexamic acid and Placenta Previa
| Article | Year |
|---|---|
Preventing deaths due to haemorrhage.
Topics: Abruptio Placentae; Antifibrinolytic Agents; Blood Transfusion; Cesarean Section; Crystalloid Soluti | 2016 |
1 trial available for tranexamic acid and Placenta Previa
| Article | Year |
|---|---|
Bilateral uterine artery ligation plus intravenous tranexamic acid during cesarean delivery for placenta previa: a randomized double-blind controlled trial.
Topics: Administration, Intravenous; Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; | 2019 |
5 other studies available for tranexamic acid and Placenta Previa
| Article | Year |
|---|---|
Use of tranexamic acid (TXA) to reduce preterm birth and other adverse obstetrical outcomes among pregnant individuals with placenta previa: a systematic review protocol.
Topics: Female; Humans; Infant, Newborn; Obstetric Labor Complications; Placenta; Placenta Previa; Postpartu | 2023 |
Aortoiliac Thrombosis Following Tranexamic Acid Administration During Urgent Cesarean Hysterectomy: A Case Report.
Topics: Adult; Antifibrinolytic Agents; Aorta, Abdominal; Balloon Occlusion; Cesarean Section; Female; Human | 2017 |
Blood-Conservation Strategies in a Blood-Refusal Parturient with Placenta Previa and Placenta Percreta.
Topics: Adult; Bloodless Medical and Surgical Procedures; Combined Modality Therapy; Erythropoietin; Female; | 2016 |
Major obstetric hemorrhage.
Topics: Blood Component Transfusion; Combined Modality Therapy; Dinoprostone; Factor VIIa; Female; Fibrinoge | 2016 |
[Possibilities of the use of an inhibitor of hemolysis (AMCHA), by rectal and vaginal administration, for gynecological hemorrhages].
Topics: Adolescent; Adult; Aged; Blood Coagulation Disorders; Child; Cyclohexanecarboxylic Acids; Female; He | 1975 |